Capstead Mortgage Corp (CMO) Stock Fundamental Analysis

NYSE:CMO

6.5
+0.16 (+2.52%)
At close: Oct 18, 2021
6.55
+0.05 (+0.77%)
After Hours: 10/18/2021, 8:43:55 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

CMO gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 68 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. CMO has a bad profitability rating. Also its financial health evaluation is rather negative. CMO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year CMO was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 1.11%
ROE 9.95%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 89.2%
PM (TTM) 74.91%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • There is no outstanding debt for CMO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

  • A Debt/Equity ratio of 7.91 is on the high side and indicates that CMO has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 7.91
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for CMO have decreased strongly by -11.67% in the last year.
  • The Earnings Per Share has been decreasing by -7.88% on average over the past years.
  • The Revenue for CMO has decreased by -57.19% in the past year. This is quite bad
  • Measured over the past years, CMO shows a decrease in Revenue. The Revenue has been decreasing by -2.90% on average per year.
EPS 1Y (TTM)-11.67%
EPS 3Y0.52%
EPS 5Y-7.88%
EPS Q2Q%-50%
Revenue 1Y (TTM)-57.19%
Revenue growth 3Y-7.17%
Revenue growth 5Y-2.9%
Sales Q2Q%-56.83%

3.2 Future

  • Based on estimates for the next years, CMO will show a small growth in Earnings Per Share. The EPS will grow by 1.36% on average per year.
  • The Revenue is expected to decrease by -7.18% on average over the next years.
EPS Next Y-2.11%
EPS Next 2Y3.92%
EPS Next 3Y0.84%
EPS Next 5Y1.36%
Revenue Next Year-39.38%
Revenue Next 2Y-19.44%
Revenue Next 3Y-13.42%
Revenue Next 5Y-7.18%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CMO Yearly Revenue VS EstimatesCMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CMO Yearly EPS VS EstimatesCMO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • CMO is valuated correctly with a Price/Earnings ratio of 12.26.
  • Compared to an average S&P500 Price/Earnings ratio of 27.07, CMO is valued rather cheaply.
  • The Price/Forward Earnings ratio is 9.26, which indicates a very decent valuation of CMO.
  • The average S&P500 Price/Forward Earnings ratio is at 28.05. CMO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.26
Fwd PE 9.26
CMO Price Earnings VS Forward Price EarningsCMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 38.02
CMO Per share dataCMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.92%
EPS Next 3Y0.84%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.77%, CMO is not a good candidate for dividend investing.
  • With a Dividend Yield of 0.77, CMO pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.77%

5.2 History

  • The dividend of CMO decreases each year by -40.61%.
  • CMO has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-40.61%
Div Incr YearsN/A
Div Non Decr YearsN/A
CMO Yearly Dividends per shareCMO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 88.97% of the earnings are spent on dividend by CMO. This is not a sustainable payout ratio.
DP88.97%
EPS Next 2Y3.92%
EPS Next 3Y0.84%
CMO Dividend Payout.CMO Dividend Payout, showing the Payout Ratio.CMO Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

Capstead Mortgage Corp

NYSE:CMO (10/18/2021, 8:43:55 PM)

After market: 6.55 +0.05 (+0.77%)

6.5

+0.16 (+2.52%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)10-27
Earnings (Next)01-11
Inst Owners0.91%
Inst Owner Change0%
Ins Owners0.8%
Ins Owner Change0%
Market Cap629.69M
Revenue(TTM)115.94M
Net Income(TTM)86.85M
Analysts100
Price Target6.97 (7.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.77%
Yearly Dividend0.05
Dividend Growth(5Y)-40.61%
DP88.97%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.26
Fwd PE 9.26
P/S 5.43
P/FCF N/A
P/OCF N/A
P/B 0.72
P/tB N/A
EV/EBITDA 38.02
EPS(TTM)0.53
EY8.15%
EPS(NY)0.7
Fwd EY10.8%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.2
BVpS9.01
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.11%
ROE 9.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 89.2%
PM (TTM) 74.91%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 7.91
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.67%
EPS 3Y0.52%
EPS 5Y-7.88%
EPS Q2Q%-50%
EPS Next Y-2.11%
EPS Next 2Y3.92%
EPS Next 3Y0.84%
EPS Next 5Y1.36%
Revenue 1Y (TTM)-57.19%
Revenue growth 3Y-7.17%
Revenue growth 5Y-2.9%
Sales Q2Q%-56.83%
Revenue Next Year-39.38%
Revenue Next 2Y-19.44%
Revenue Next 3Y-13.42%
Revenue Next 5Y-7.18%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Capstead Mortgage Corp / CMO FAQ

What is the ChartMill fundamental rating of Capstead Mortgage Corp (CMO) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CMO.


What is the valuation status of Capstead Mortgage Corp (CMO) stock?

ChartMill assigns a valuation rating of 3 / 10 to Capstead Mortgage Corp (CMO). This can be considered as Overvalued.


How profitable is Capstead Mortgage Corp (CMO) stock?

Capstead Mortgage Corp (CMO) has a profitability rating of 3 / 10.


What is the financial health of Capstead Mortgage Corp (CMO) stock?

The financial health rating of Capstead Mortgage Corp (CMO) is 1 / 10.


Can you provide the dividend sustainability for CMO stock?

The dividend rating of Capstead Mortgage Corp (CMO) is 2 / 10 and the dividend payout ratio is 88.97%.